Development of a Machine Learning Model to Predict Outcomes and Cost After Cardiac Surgery.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
06 2023
Historique:
received: 17 12 2021
revised: 25 04 2022
accepted: 18 06 2022
medline: 26 5 2023
pubmed: 3 8 2022
entrez: 2 8 2022
Statut: ppublish

Résumé

Machine learning (ML) algorithms may enhance outcomes prediction and help guide clinical decision making. This study aimed to develop and validate a ML model that predicts postoperative outcomes and costs after cardiac surgery. The Society of Thoracic Surgeons registry data from 4874 patients who underwent cardiac surgery (56% coronary artery bypass grafting, 42% valve surgery, 19% aortic surgery) at our institution were divided into training (80%) and testing (20%) datasets. The Extreme Gradient Boosting decision-tree ML algorithms were trained to predict three outcomes: operative mortality, major morbidity or mortality, and Medicare outlier high hospitalization cost. Algorithm performance was determined using accuracy, F1 score, and area under the precision-recall curve (AUC-PR). The ML algorithms were validated in index surgery cases with The Society of Thoracic Surgeons risk scores for mortality and major morbidities and with logistic regression and were then applied to nonindex cases. The ML algorithms with 25 input parameters predicted operative mortality (accuracy 95%; F1 0.31; AUC-PR 0.21), major morbidity or mortality (accuracy 71%, F1 0.47; AUC-PR 0.47), and high cost (accuracy 84%; F1 0.62; AUC-PR 0.65). Preoperative creatinine, complete blood count, patient height and weight, ventricular function, and liver dysfunction were important predictors for all outcomes. For patients undergoing nonindex cardiac operations, the ML model achieved an AUC-PR of 0.15 (95% CI, 0.05-0.32) for mortality and 0.59 (95% CI, 0.51-0.68) for major morbidity or mortality. The extreme gradient boosting ML algorithms can predict mortality, major morbidity, and high cost after cardiac surgery, including operations without established risk models. These ML algorithms may refine risk prediction after cardiac surgery for a wide range of procedures.

Sections du résumé

BACKGROUND
Machine learning (ML) algorithms may enhance outcomes prediction and help guide clinical decision making. This study aimed to develop and validate a ML model that predicts postoperative outcomes and costs after cardiac surgery.
METHODS
The Society of Thoracic Surgeons registry data from 4874 patients who underwent cardiac surgery (56% coronary artery bypass grafting, 42% valve surgery, 19% aortic surgery) at our institution were divided into training (80%) and testing (20%) datasets. The Extreme Gradient Boosting decision-tree ML algorithms were trained to predict three outcomes: operative mortality, major morbidity or mortality, and Medicare outlier high hospitalization cost. Algorithm performance was determined using accuracy, F1 score, and area under the precision-recall curve (AUC-PR). The ML algorithms were validated in index surgery cases with The Society of Thoracic Surgeons risk scores for mortality and major morbidities and with logistic regression and were then applied to nonindex cases.
RESULTS
The ML algorithms with 25 input parameters predicted operative mortality (accuracy 95%; F1 0.31; AUC-PR 0.21), major morbidity or mortality (accuracy 71%, F1 0.47; AUC-PR 0.47), and high cost (accuracy 84%; F1 0.62; AUC-PR 0.65). Preoperative creatinine, complete blood count, patient height and weight, ventricular function, and liver dysfunction were important predictors for all outcomes. For patients undergoing nonindex cardiac operations, the ML model achieved an AUC-PR of 0.15 (95% CI, 0.05-0.32) for mortality and 0.59 (95% CI, 0.51-0.68) for major morbidity or mortality.
CONCLUSIONS
The extreme gradient boosting ML algorithms can predict mortality, major morbidity, and high cost after cardiac surgery, including operations without established risk models. These ML algorithms may refine risk prediction after cardiac surgery for a wide range of procedures.

Identifiants

pubmed: 35917942
pii: S0003-4975(22)00997-3
doi: 10.1016/j.athoracsur.2022.06.055
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1533-1542

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Rodrigo Zea-Vera (R)

Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.

Christopher T Ryan (CT)

Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.

Sergio M Navarro (SM)

Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.

Jim Havelka (J)

InformAI, Houston, Texas.

Matthew J Wall (MJ)

Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.

Joseph S Coselli (JS)

Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas; Cardiothoracic Surgery, Texas Heart Institute, Houston, Texas.

Todd K Rosengart (TK)

Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas; Cardiothoracic Surgery, Texas Heart Institute, Houston, Texas.

Subhasis Chatterjee (S)

Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas; Cardiothoracic Surgery, Texas Heart Institute, Houston, Texas.

Ravi K Ghanta (RK)

Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas; Cardiothoracic Surgery, Texas Heart Institute, Houston, Texas. Electronic address: ravi.ghanta@bcm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH